RxDoctor Payments Data

Shelby Romine, APRN

Family · Louisville, KYNPI 1902578735

Payments from drug & device makers

$1,294in general payments, 2019–2025

Across 69 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$144
  • Teva Pharmaceuticals USA, Inc.$143
  • Johnson & Johnson$134
  • Alkermes, Inc.$105
  • Otsuka America Pharmaceutical, Inc.$83
  • Lundbeck LLC$69
  • plus $616 from 18 others

What the payments were for

  • Food & beverage$1,294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,294 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$14,264
Medicare patients
53
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$29,219
EliquisApixaban27$18,101
LinzessLinaclotide18$13,077
OzempicSemaglutide13$12,503
JardianceEmpagliflozin11$11,201
Breo ElliptaFluticasone/Vilanterol17$7,178
Ondansetron Hcl17$2,824
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,869
Ventolin HfaAlbuterol Sulfate22$1,226
Albuterol Sulfate HfaAlbuterol Sulfate67$1,210
Levothyroxine Sodium55$888
Fluticasone Propionate58$598
Gabapentin54$559
Atorvastatin Calcium86$556
Dicyclomine Hcl27$515

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$38$36,39756 claims
AbbVieLinzess$48$13,07718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →